JPS56108712A - Lecithin cholesterol acyl transferase activator - Google Patents

Lecithin cholesterol acyl transferase activator

Info

Publication number
JPS56108712A
JPS56108712A JP1073780A JP1073780A JPS56108712A JP S56108712 A JPS56108712 A JP S56108712A JP 1073780 A JP1073780 A JP 1073780A JP 1073780 A JP1073780 A JP 1073780A JP S56108712 A JPS56108712 A JP S56108712A
Authority
JP
Japan
Prior art keywords
lecithin
pantethine
activator
lcat
acyl transferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1073780A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6345371B2 (enrdf_load_stackoverflow
Inventor
Toyoichiro Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP1073780A priority Critical patent/JPS56108712A/ja
Publication of JPS56108712A publication Critical patent/JPS56108712A/ja
Publication of JPS6345371B2 publication Critical patent/JPS6345371B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1073780A 1980-01-31 1980-01-31 Lecithin cholesterol acyl transferase activator Granted JPS56108712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1073780A JPS56108712A (en) 1980-01-31 1980-01-31 Lecithin cholesterol acyl transferase activator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1073780A JPS56108712A (en) 1980-01-31 1980-01-31 Lecithin cholesterol acyl transferase activator

Publications (2)

Publication Number Publication Date
JPS56108712A true JPS56108712A (en) 1981-08-28
JPS6345371B2 JPS6345371B2 (enrdf_load_stackoverflow) 1988-09-09

Family

ID=11758600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1073780A Granted JPS56108712A (en) 1980-01-31 1980-01-31 Lecithin cholesterol acyl transferase activator

Country Status (1)

Country Link
JP (1) JPS56108712A (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034811A1 (en) * 1993-06-11 1995-12-21 Oculon Corporation Protein condensation inhibitors and methods related thereto
WO2015050148A1 (ja) * 2013-10-04 2015-04-09 第一三共株式会社 ３－アリールピラゾロピリジン誘導体
WO2015076353A1 (ja) * 2013-11-25 2015-05-28 第一三共株式会社 ３－アルキルピラゾロピリジン誘導体

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034811A1 (en) * 1993-06-11 1995-12-21 Oculon Corporation Protein condensation inhibitors and methods related thereto
WO2015050148A1 (ja) * 2013-10-04 2015-04-09 第一三共株式会社 ３－アリールピラゾロピリジン誘導体
WO2015076353A1 (ja) * 2013-11-25 2015-05-28 第一三共株式会社 ３－アルキルピラゾロピリジン誘導体

Also Published As

Publication number Publication date
JPS6345371B2 (enrdf_load_stackoverflow) 1988-09-09

Similar Documents

Publication Publication Date Title
USD259278S (en) Tubing connector for blood and other medical applications
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
ATE66614T1 (de) Insulinzubereitung fuer nicht-parenterale verabreichung.
DE69033560D1 (de) Arzneimittel für insulinresistente diabetiker
ES8201596A1 (es) Procedimiento de obtencion de mucopolisacaridos
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
ATE65696T1 (de) Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
IE873245L (en) Administering a deoxythymidine
ATE65912T1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
SE7711102L (sv) Nya medel och nya sett att behandla klimakteriska bortfallsymptom
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
Huang et al. Visual disturbances in cystic fibrosis following chloramphenicol administration
JPS56108712A (en) Lecithin cholesterol acyl transferase activator
FR2362849A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
EG17992A (en) Preparation of a medicament for arthritis and theumatism
NO862321D0 (no) Fysiologisk middel for oekning av transdermal avlevering av legemidler.
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
ATE55254T1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
SU637117A1 (ru) Способ диагностики туберкулеза
Rich et al. Agranulocytosis resulting from methimazole (tapazole): report of three cases
熊宁宁 et al. EFFECTS OF TCM THERAPY ON THE PROGRESSION OF CHRONIC RENAL FAILURE CAUSED BY PRIMARY GLOMERULONEPHRITIS
Cidad Metabolic effects of beta-blocking drugs. Their association with diuretics in the treatment of arterial hypertension.